Evolent Health, Inc. EVH
Set alert
4.30 USD +0.05 +1.18%
At close · Oct 30
4.30 0.00 0.00%
After hours · Oct 30, 4:01 PM ET
4.09 Day range 4.31
2.17 52-week range 6.72
- YTD
- +7.50%
- 1 year
- -34.85%
- Open
- 4.26
- Prev close
- 4.25
- Mkt cap
- 486.16M
- Vol
- 1.15M
- Avg vol
- 2.54M
- EPS
- -4.49
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.09
- High
- 4.31
- Forward P/E
- 6.01
- Beta
- 0.73
- Short ratio
- 6.55
- Inst. own
- 108.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2025
- 50-d avg
- 9.86
- 200-d avg
- 9.96
- 1y target
- 15.46
2Y chart
Events in this range
- Nov 7, 2024Earnings: 0.04; estimate 0.3; surprise -86.67%
- May 8, 2025Earnings: 0.06; estimate 0.09; surprise -33.33%
- May 13, 2025Rating: Needham · Buy → Buy
- Jun 20, 2025Rating: JMP Securities · Market Outperform → Market Outperform
- Jul 17, 2025Rating: Truist Securities · Buy → Buy
- Aug 7, 2025Earnings: —; estimate 0.09; surprise -211.11%
- Aug 28, 2025Rating: Piper Sandler · Overweight → Overweight
- Sep 9, 2025Rating: BTIG · Buy → Buy
- Sep 9, 2025Rating: Canaccord Genuity · Buy → Buy
- Nov 6, 2025Earnings: —; estimate 0.1; surprise —%
Signals (74)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 28, 2026 | 3 days ago |
| RSI: Overbought | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 1 month ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| RSI: Oversold | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 16, 2026 | 3 months ago |
| RSI: Overbought | Jul 14, 2026 | 3 months ago |
| RSI: Overbought | Jun 26, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 12, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 8, 2026 | 4 months ago |
| MACD: Sell Signal | May 18, 2026 | 5 months ago |
| RSI: Overbought | May 7, 2026 | 5 months ago |
| RSI: Overbought | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 15, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 7, 2026 | 6 months ago |
| RSI: Oversold | Mar 30, 2026 | 7 months ago |
| RSI: Oversold | Mar 24, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 17, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bullish | Mar 2, 2026 | 8 months ago |
| RSI: Oversold | Feb 24, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 19, 2026 | 8 months ago |
| RSI: Oversold | Jan 28, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 27, 2026 | 9 months ago |
| RSI: Oversold | Dec 1, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| RSI: Oversold | Nov 5, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 29, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 21, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 30, 2025 | 1 year ago |
| SMA: Bearish | Sep 25, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 25, 2025 | 1 year ago |
| SMA: Bullish | Sep 24, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 22, 2025 | 1 year ago |
| SMA: Bearish | Aug 5, 2025 | 1 year ago |
| SMA: Bullish | Jul 30, 2025 | 1 year ago |
| SMA: Bearish | Jul 29, 2025 | 1 year ago |
| SMA: Bullish | Jul 25, 2025 | 1 year ago |
| SMA: Bearish | Jul 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 14, 2025 | 1 year ago |
| RSI: Overbought | Jun 25, 2025 | 1 year ago |
| SMA: Bullish | Jun 20, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 4, 2025 | 1 year ago |
| RSI: Oversold | May 22, 2025 | 1 year ago |
| MACD: Sell Signal | May 12, 2025 | 1 year ago |
| SMA: Bearish | May 9, 2025 | 1 year ago |
| SMA: Bullish | Apr 29, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 29, 2025 | 1 year ago |
| SMA: Bearish | Apr 15, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 15, 2025 | 1 year ago |
| SMA: Bullish | Apr 9, 2025 | 1 year ago |
| SMA: Bearish | Apr 7, 2025 | 1 year ago |
| SMA: Bullish | Apr 2, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 11, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 28, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 17, 2025 | 1 year ago |
| RSI: Oversold | Dec 12, 2024 | 1 year ago |
Key statistics
- Market cap
- 997.35M
- Enterprise value
- 1.98B
- Trailing P/E
- 0.00
- Forward P/E
- 6.01
- PEG ratio
- 0.00
- Price / sales
- 0.45
- Price / book
- 1.11
- EPS (TTM)
- -1.60
- Beta
- 0.73
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -5.94%
- Revenue (TTM)
- 2.20B
- Revenue growth
- -31.30%
- Free cash flow
- -77.39M
- Total cash
- 151.00M
- Total debt
- 853.19M
- Return on equity
- -11.04%
- Shares outstanding
- 115.97M
- Short % of float
- 19.74%
- 50-day average
- 9.86
- 200-day average
- 9.96
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 15.46 +259.6% upside
Now 4.30
- Target (low)
- 9.00
- Target (mean)
- 15.46
- Target (high)
- 20.00
Ratings (0m) 14 13 buy · 1 hold · 0 sell
- Strong buy4
- Buy9
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 6, 2025
Expected Nov 6, 2025. Consensus EPS estimate 0.10522.
Financials — quick view
EVH Revenue — quarterly 652.52M
EVH Net income — quarterly -28.36M
EVH EPS — quarterly -0.25
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2025 | Sep 1, 2025 | 0.10 | — | — | — |
| Aug 7, 2025 | Jun 1, 2025 | 0.09 | — | -0.19 | -211.11% |
| May 8, 2025 | Mar 1, 2025 | 0.09 | 0.06 | -0.03 | -33.33% |
| Nov 7, 2024 | Sep 1, 2024 | 0.30 | 0.04 | -0.26 | -86.67% |
| Aug 8, 2024 | Jun 1, 2024 | 0.21 | 0.30 | +0.09 | +42.86% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 9, 2025 | Canaccord Genuity | main | Buy | Buy |
| Sep 9, 2025 | BTIG | reit | Buy | Buy |
| Aug 28, 2025 | Piper Sandler | main | Overweight | Overweight |
| Jul 17, 2025 | Truist Securities | main | Buy | Buy |
| Jun 20, 2025 | JMP Securities | reit | Market Outperform | Market Outperform |
| May 13, 2025 | Needham | reit | Buy | Buy |
About Evolent Health, Inc.
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- evolent.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on EVH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARBAROSH CRAIG A | Director | Stock Award(Grant) | Jun 4, 2025 | 53,935 |
| BLACKLEY SETH | Chief Executive Officer | Stock Award(Grant) | Jun 30, 2025 | 829,367 |
| GRUA PETER J | Director | Stock Award(Grant) | Jun 4, 2025 | 82,647 |
| GUERTIN SHAWN M | Director | Stock Award(Grant) | Jun 4, 2025 | 21,979 |
| JELINEK RICHARD M | Director | Stock Award(Grant) | Jun 4, 2025 | 66,437 |
| JOHNSON JOHN PAUL | Chief Financial Officer | Stock Award(Grant) | Jun 30, 2025 | 309,245 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 9.29% | 10,921,531 | 93.93M | Jun 29, 2025 |
| Cadian Capital Management, LP | 8.87% | 10,424,701 | 89.65M | Jun 29, 2025 |
| Blackrock Inc. | 7.98% | 9,376,620 | 80.64M | Jun 29, 2025 |
| Morgan Stanley | 6.85% | 8,052,587 | 69.25M | Jun 29, 2025 |
| Durable Capital Partners Lp | 5.47% | 6,423,293 | 55.24M | Jun 29, 2025 |
| FMR, LLC | 5.46% | 6,420,384 | 55.22M | Jun 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 5.77% | 6,778,267 | 58.29M | Apr 29, 2025 |
| Fidelity Securities Fund-Fidelity Small Cap Value Fund | 3.31% | 3,894,086 | 33.49M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.04% | 3,567,642 | 30.68M | Jun 29, 2025 |
| iShares Trust-iShares Russell 2000 ETF | 2.47% | 2,906,857 | 25.00M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.32% | 2,725,731 | 23.44M | Jun 29, 2025 |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 1.76% | 2,070,815 | 17.81M | Jun 29, 2025 |